We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

[OXFORD]  In response to the growing Ebola crisis in West Africa, scientists in the United Kingdom and United States last week launched human trials of an Ebola vaccine candidate, and the plan is to carry out trials in Mali too within the next few weeks.
SciDev.Net spoke to Adrian Hill, director of the Jenner Institute at the University of Oxford and lead researcher for the UK-based trials. He told us about the exceptionally fast review process that enabled scientists to start the trials within a few weeks rather than the usual 6-12 months, the international collaboration driving the fight against Ebola, and his hope that a vaccine could be available by the end of the year. 

Related topics